Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole PK in Lung Transplant Recipients
NCT01667107Phase 4Terminated
- Sponsor
- Merck & Co.
- Start
- Jan 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of posaconazole in fungal infection, sponsored by Merck & Co.. Started Jan 2013; status: terminated.
02
Drugs
posaconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT01667107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667107.